Para Genetics

An Overview of Current Paranormal Genetic Theory

Introduction

Since the 1940s, people with extraordinary talents – superpowers – have been appearing in the human population. The powers range from practically inconsequential to the level of national security threats. What follows is a brief overview of the genetic component of Paranormal abilities.

Evolutionary Biology

It is postulated that the Paranormal gene complex were introduced into the population between the Mitochondrial Eve (c. 150,000 YBP) and the theorized Toba Catastrophe (c 75,000 YBP).

Currently, the average chance of known paranormals is at 1.7 to 2.0 per 100,000. Paranormal expression appears to be slightly higher in certain aboriginal populations, namely Native Americans, Ainu, and the native Australians. Why these groups and not others? It has been suggested that the Para-genes happened to be more common in lineages which founded these groups, just as certain blood types are more common in some than others. It is also likely that Paranormal expression was stigmatized in some cultures to a greater degree. For instance, the ability to see into the future or survive terrible wounds might be seen as divine favor in a hunter-gatherer society, while suggesting witchcraft in Medieval Europe. Whether cultural or by chance, the genes seem underrepresented in ancestral European, African and Asian stock, yet over represented in certain marginalized genomes. That said, the quiet (often stigmatized) mixing of bloodlines in recent centuries has spread the Para-genes into new populations at a considerable rate. This may explain why North and Central America have higher rates of Paranormal expression than Europe .

Genetics

Paranormal abilities are complex traits stemming from expression of polygenic interactions. These abilities almost always manifest around puberty, but have been known to occur at any point.

There are a handful of genes that relate to paranormal expression. When activated, they interact to determine the nature and strength of the powers. These interactions are governed by a single “control” gene (P_c); the active allele is recessive. A person may have all, some, or none of the genes.

If an individual has P_c P_c, no powers will be expressed. An individual with P_c p_cshouldn’t manifest paranormal abilities, although it has been argued that a partial expression is possible.

An individual with p_c p_c is expected to activate their paranormal genes. What triggers the control gene to “switch on” is not fully understood at this time, although it is generally agreed that environmental factors (in particular the increased environmental radiation from nuclear testing) plays a role. Even among Paranormals, few have a full compliment of the Paranormal genes, which is why most manifested powers are within “normal” human parameters or expectations.

Gene Therapy

The first successful attempt to affect the expression of Paranomality was the Hyche Vaccine, which was first publicized in 2002. Hyche used gene therapy to replace one recessive allele on the control gene with a dominant allele, essentially switching off the Para-gene complex. While largely successful, the number of cases with either no effect or adverse effects to treatment was grossly underreported.

Recently, the Corbin-Beaumont Vaccine was announced. Though not yet tested, it is expected to work in reverse fashion to Hyche, substituting a recessive for a dominant allele. Whether it might change two dominants for two recessives is not yet clear.

Implications

Considering that a tiny fraction of the human population shows any extraordinary abilities, the effect of Paranormal activity on the world in the past 60 years is not inconsequential. The knowledge that as many as a quarter of the world’s population carry the genes for superpowers is unsettling; the notion that the carriers can actually develop their powers with gene therapy will do more to change the social fabric of every culture than anything in recorded history.

Links: